Can a brief home therapy cut suicide reattempts? new study aims to find out

NCT ID NCT06322199

Ongoing Disease control Sponsor: University of Bern Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a short, home-based therapy called ASSIP Flex for adults who have attempted suicide. The therapy involves 3-4 sessions delivered in the patient's own environment. Researchers will track suicidal thoughts and behaviors over 12 months to see if the therapy is feasible, cost-effective, and helps reduce repeat attempts. The study enrolls 119 participants in Switzerland.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ASSIP Flex (a brief, home-based behavioral therapy for people who have attempted suicide)
What this could lead to: If it works, this could provide an effective, cost-saving way to deliver suicide prevention therapy at home, reducing repeat attempts.
What could go wrong: This is a small feasibility study (119 people) with no control group, so results may not prove effectiveness. The therapy may not work for everyone, and some participants might drop out.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COST-EFFECTIVENESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Suicidal Ideation Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COST-EFFECTIVENESS FEASIBILITY PROCESS FACTORS SUICIDAL IDEATION SUICIDE, ATTEMPTED

Contacts and locations

Locations

Center Neuchâtelois de Psychiatrie

Neuchâtel, Switzerland
Centre Hospitalier universitaire vaudois (CHUV)

Lausanne, Switzerland
Psychiatric Hospital, University of Zurich (PUKZH)

Zurich, Switzerland
Sanatorium Kilchberg

Zurich, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.